Monroe, LA, United States of America

Girish Shah

This inventor holds 3 USPTO granted patents. Top assignee: University of Louisiana at Monroe. Active years: 2010-2012.


% Patents Active = 33.3

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Girish Shah: Innovator in Anti-Cancer Research

Introduction

Girish Shah is a notable inventor based in Monroe, Louisiana, who has made significant contributions to the field of cancer research. With a focus on developing innovative compounds and methods for cancer treatment, he holds a total of 3 patents that reflect his dedication to advancing medical science.

Latest Patents

Shah's latest patents include groundbreaking work on anti-cancer hydantoin compounds and methods. This invention relates to methods for treating or preventing cancer, utilizing novel compositions that share features with specific imidazolidine derivatives. The compounds developed have demonstrated anti-cancer effects, including anti-metastatic, anti-growth, and anti-invasive activities. Another significant patent involves anticancer tobacco cembranoids, which describes a method of delivering compounds to areas containing cancer cells, showcasing his innovative approach to cancer treatment.

Career Highlights

Girish Shah is affiliated with the University of Louisiana at Monroe, where he continues to engage in research and development in the field of oncology. His work is characterized by a commitment to finding effective solutions for cancer treatment, which is evident in his patented inventions.

Collaborations

Shah has collaborated with esteemed colleagues such as Khalid A El Sayed and Paul Sylvester, contributing to a rich environment of research and innovation.

Conclusion

Girish Shah's contributions to cancer research through his patents and collaborations highlight his role as a significant inventor in the medical field. His innovative approaches aim to improve treatment options for cancer patients, showcasing the importance of research in combating this disease.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…